Lebrikizumab maintains improvements in the patient-oriented eczema measure through 2 years of treatment in patients with moderate-to-severe atopic dermatitis [Abstract]

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:David Rosmarin, Andreas Wollenberg, Mark Boguniewicz, Carolyn Jack, Sebastien Barbarot, Vivian Shi, Marjolein de Bruin-Weller, Louise DeLuca-Carter, Evangeline Pierce, Chaoran Hu, Chunyuan Liu, Heidi Crane, Laia Bardolet, Martin Steinhoff
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/111463
ISSN:0091-6749OPAC
Parent Title (English):Journal of Allergy and Clinical Immunology
Publisher:Elsevier BV
Type:Article
Language:English
Date of first Publication:2024/02/05
Release Date:2024/02/20
Tag:Immunology; Immunology and Allergy
Volume:153
Issue:2, Supplement
First Page:AB7
DOI:https://doi.org/10.1016/j.jaci.2023.11.045
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Dermatologie